Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Xavier Mariette

1-50 of 399 results

View this query on the Wikidata Query Service
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

scientific article
Genetics of rheumatoid arthritis contributes to biology and drug discovery

scientific article
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

scientific article published on 6 March 2017
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

scientific article published in July 2002
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates

scientific article published on 23 February 2009
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

scholarly article
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

scientific article
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome

scientific article published on 6 October 2013
High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe

scientific article published on 7 November 2005
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry

scientific article published on August 2010
Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France

scientific article published in June 2002
Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

scientific article published on September 2011
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.

scientific article published in Annals of the Rheumatic Diseases, 26 October 2016
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

scientific article
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

scientific article published on April 2004
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.

scientific article published on 16 April 2014
Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective

scientific article
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

scientific article
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome

scientific article published on 22 February 2011
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

scientific article
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts

scientific article published in Arthritis & Rheumatology, 2016
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity

scientific article published on 15 October 2009
Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis

scientific article
Advances in understanding the pathogenesis of primary Sjögren's syndrome

scientific article published on 16 July 2013
Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid

scientific article published on February 2013
Association of an IRF5 gene functional polymorphism with Sjögren's syndrome

scientific article published on December 2007
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

scientific article
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome

scientific article
Treatment of primary Sjögren syndrome with rituximab: a randomized trial

scientific article published in February 2014
RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone

scientific article published on 01 February 2002
Sjögren syndrome

Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome

scientific article published in April 2004
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production

scientific article
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial

scientific article
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.

scientific article
Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

scientific article published on 17 December 2013
Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries

scientific article
Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?

scientific article published on 7 September 2004
Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis

scientific article
The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients

scientific article published on 26 July 2007
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

scientific article published on March 2016
Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).

scientific article published on 17 January 2014
Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis

scientific article published on December 1, 2011
CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome

scientific article published on 01 May 2005
Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

scientific article published on January 2006
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy

scientific article published on 01 July 2003
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial

scientific article
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

scientific article published on 5 December 2014
Usefulness of 2‐[18F]‐fluoro‐2‐deoxy‐d‐glucose–Positron Emission Tomography/Computed Tomography for Staging and Evaluation of Treatment Response in IgG4‐Related Disease: A Retrospective Multicenter Study

scientific article published on January 1, 2014

Paulina is supported by:

About Paulina

Help